pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. She holds a degree in biochemistry from Oxford University.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

European Pharmaceutical Review

MARCH 24, 2023

According to GlobalData, competition to develop a first-to-market drug for NASH is strong. In NASH, excess fat in the liver can lead to progressive disease, including inflammation, liver cell injury and fibrosis, which are associated with increased risk for cardiovascular disease and liver morbidity and mortality.

Medical 108

Medical Side effects Safety Pharmaceutical 108

pharmaphorum

NOVEMBER 8, 2022

At the moment, most insulin dosing information is recorded manually in a logbook or app, and human error can lead to inaccurate or incomplete information that can impact on blood sugar control. billion in 2020 to more than $16 billion by 2030, according to GlobalData.

Management 64

Management Marketing Physicians Education 64

Clarify Health

APRIL 18, 2024

As both government and commercial payers direct a greater share of volume to out-patient facilities and patient demand for same-day service increases, opportunity and competition in the ambulatory surgical center (ASC) space are increasing. Is there an ASC in your market you should merge with or acquire?

Marketing 52

Marketing Competition Physicians Management 52

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. from 2023 to 2030. Poised to grow at a CAGR of 29.4% billion in 2022 and will expand at a CAGR of 10.3%

Pharma 52

Pharma Medicine Marketing Prospecting 52

Sales Talent

JANUARY 20, 2022

However, before you jump directly to our sales hiring predictions for 2022, take the time to read the entire article to learn how the intense competition for talent is impacting sales professionals’ salaries and employers’ strategies for winning the talent war. jobs by 2030 while the workforce will only grow by 8.9M.

Sales 52

Sales B2B Sales Competition Insurance 52

Healthcare Success

NOVEMBER 14, 2022

billion in 2030 ). Analyzing your data and creating buyer personas to support your data will help you better understand your target audience, increase leads, and improve your inbound medical device marketing strategy. Generate Leads with Paid Search (Pay-Per-Click, PPC). billion in 2022 to 964.90

Medical 70

Medical Marketing Engineering Doctors 70

Every Ancillary

MAY 14, 2021

According to one estimate from P&S Research , this market is expected to grow nearly 5x by 2030! Cons: Highly competitive with new options continually emerging. Delivers real clinical value leading to more effective treatment plans. Pros: A growing market means a good chance for long-term success with each client.

Medical sales 52

Medical sales Medical Sales Insurance 52

Spotio

MARCH 25, 2024

In fact, experts claim that 15% of American households will have solar photovoltaic (PV) systems in place by 2030. This indicates enormous potential for solar companies—but competition for business is fierce. Your company will be compared to the competition to see how it stacks up. If it can’t, it won’t.

Sales 52

Sales Prospecting Sales process Sales pitches 52

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. However, this can lead to several issues, such as: Implantation resistance due to reactionary metabolism Allergic reactions to the nickel component found in stainless steel composites Widespread bone destruction due to immunological responses to cobalt particles. The US-based Enovis is leading this new development.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

Spotio

FEBRUARY 9, 2023

Furthermore, the organization predicts it will outpace the GDP by 2030. Increased competition Your sales team also faces more competition than ever before. This method won’t cut it in years to come if you expect to separate yourself from the competition. The medical field is growing. What does this look like?

Sales 52

Sales Medical Doctors Sales process 52

LEVO Health

MAY 8, 2024

Cultural and Language Barriers: Differences in language and culture can lead to miscommunication and reduced patient engagement. Top Strategies to Improve Patient Engagement in Healthcare Practices must consistently attract and retain patients to stay ahead in the competitive healthcare market.

Healthcare 52

Healthcare Healthcare Patients Healthcare Provider 52

PM360

AUGUST 9, 2022

2 The use of emerging technology here will lead to an even more diverse landscape of launches and approaches to commercialization. ZS analysis shows the top pharma companies have more than $230B in worldwide revenues at risk from 2022 to 2030; the top 10 pharma companies combined have more than 45% of their revenues at risk.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Pharmaceutical Technology

DECEMBER 15, 2022

With its highly educated, English-speaking workforce and high-quality medical facilities system, Singapore has attracted leading pharmaceutical companies to open their regional headquarters in the city-state, including Novo Nordisk (Bagsvaerd, Denmark) and GSK.

Manufacturing 105

Manufacturing Pharma Engineering Government 105

Pharmaceutical Technology

FEBRUARY 24, 2023

The WHO’s 2020 global strategy sets out its vision of cervical cancer being eliminated as a public health problem by 2030 and outlines a pathway with strategic actions to achieve its goal. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Prospecting 116

Prospecting Competition Medicine Leads 116

Clarivate

DECEMBER 14, 2023

IDNs coalesce along Competitive Service Regions As nonprofit IDNs push out from their home markets and for-profit and Catholic IDNs pull back from earlier expansions, distinct competitive service regions with common rivalries are developing across the nation. Typically, BCBS plans offer an iteration of VBC to providers in their state.

Marketing 52

Marketing Healthcare Healthcare Insurance 52